GILD vs SPIR · P/E 18, rev $29.44B vs rev $110.5M
Gilead Sciences Inc (GILD) versus Spire Global Inc (SPIR) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Spire Global Inc (SPIR) is a specialty business services company listed on US.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported SPIR revenue for 2024-12-31 was $110.5M. Net income was -$102.8M. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. SPIR currently screens at market cap $351.2M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. SPIR currently screens at market cap $351.2M.
Not investment advice. Open the GILD and SPIR stock pages for the full models.
Not investment advice.